Achieving HCV Elimination in the United States: Progress and Next Steps

In this online educational program, expert faculty explore what will be needed to achieve HCV elimination in the United States. Choose from 6 short foundational videos, 3 ClinicalThought commentaries, and a module with accompanying slideset that details answers to commonly asked questions on the management of key at-risk populations.
Frederick L. Altice, MD
Christian Ramers Headshot
Christian B. Ramers, MD, MPH
Lara Strick, MD, MS

ClinicalThought

With long-term health and wellness as a framing principle, curing HCV is not the finish line but rather a starting point for a conversation about maintaining wellness, preventing progression of liver disease, addressing harmful drug and alcohol habits, and, of importance, preventing HCV reinfection.

Christian Ramers Headshot Christian B. Ramers, MD, MPH Released: November 30, 2017

Implementation of prevention services targeting incarcerated patients is possible. Let me tell you why.

Lara Strick, MD, MS Released: December 12, 2017

Eliminating HCV infection among persons who inject drugs is a daunting task whether tackling it from a patient care perspective, through practice transformation, or by influencing policies that improve access to treatment. Nonetheless, there are practical steps that can be taken by clinicians to improve the HCV continuum of care for this challenging population. Here’s my take on some of those steps.

Frederick L. Altice, MD Released: January 19, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue